REEVE GRAHAM D.
COO
REEVE GRAHAM D. has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.
On the most recent filing, REEVE GRAHAM D. is listed as COO at U S PHYSICAL THERAPY INC /NV. Inside the rolling window, REEVE GRAHAM D. reported no open-market purchases and 4 open-market sales totaling $254K in USPH. The largest disclosed transaction in the window is a sale of 1,807 USPH shares on Mar 6, 2026, worth $149K.
Companies traded
Other insiders at USPH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$254K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has REEVE GRAHAM D. made?
REEVE GRAHAM D. has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does REEVE GRAHAM D. trade?
REEVE GRAHAM D. has filed SEC Form 4 disclosures for 1 company, including USPH.
When was REEVE GRAHAM D.'s most recent SEC Form 4 filing?
REEVE GRAHAM D.'s most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.
What is REEVE GRAHAM D.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, REEVE GRAHAM D. is listed as COO.
What is REEVE GRAHAM D.'s total buy and sell value in the current window?
Inside the rolling retention window, REEVE GRAHAM D. bought $0 and sold $254K based on SEC Form 4 filings.
What was REEVE GRAHAM D.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,807 USPH shares on 2026-03-06, worth $149K, per SEC Form 4 filings.